- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UK-06-0011501

About Zaneka Pharmaceuticals Private Limited
Data last updated:
Zaneka Pharmaceuticals Private Limited is a private limited company based in Haridwar, Uttarakhand, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 May 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U24231UR1999PTC001430. Its GSTIN is 05AAACZ1224A1Z3 (Uttarakhand). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Shifali and Satish Chand Virmani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 120 Dwarika Vihar Salempur Mehdood Bahadrabad, Haridwar, Uttarakhand, India – 249402.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.17 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹6.37 Lakh (net margin 1.5%) and EBITDA of ₹14.74 Lakh (EBITDA margin 3.5%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 7% over five years.
The company has about 17 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Zaneka Pharmaceuticals. As per MCA filings, the company has open charges of ₹90 Lakh and satisfied charges of ₹22 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it.
Zaneka Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-06-0011501). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website zanekapharma.com.
Company details
CIN history
Zaneka Pharmaceuticals has one previous CIN (Corporate Identification Number): U24231DL1999PTC099952. The current CIN is U24231UR1999PTC001430, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231UR1999PTC001430 | Current |
| U24231DL1999PTC099952 | Previous |
Recognitions & Rankings of Zaneka Pharmaceuticals
Contact details
Zaneka Pharmaceuticals Private Limited's registered office is in Haridwar, Uttarakhand. Its website is zanekapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address120 Dwarika Vihar Salempur Mehdood Bahadrabad, Haridwar, Uttarakhand, India – 249402
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Zaneka Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Zaneka Pharmaceuticals operates one associated brand: Zaneka Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical company offering a range of high-quality pharmaceutical products. | zanekapharma.com |
Business activity
The main business activity of Zaneka Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Zaneka Pharmaceuticals Private Limited, buy the company report.
Financials of Zaneka Pharmaceuticals Private Limited
FY 2025 filings availableZaneka Pharmaceuticals Private Limited reported revenue of ₹4.17 Cr (down 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 7% over five years, including a 3% fall in the latest year. EBITDA fell 41% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.74 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.37 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.5% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zaneka Pharmaceuticals Private Limited, buy the company report.
Board of directors of Zaneka Pharmaceuticals Private Limited
Zaneka Pharmaceuticals has 8 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shifali | Director | 30 Jun 2011 | 15 Years 4 Months | Current |
| Satish Chand Virmani | Director | 30 Jun 2011 | 15 Years 4 Months | Current |
| Amit Virmani | Director | 30 Jun 2011 | 15 Years 4 Months | Current |
| Shantanu Virmani Also directs: BLS the Elite Club LLP, Twenty Twenty Eye Care Private Limited, QCD Agro LLP and 1 more | Director | 30 Jun 2011 | 15 Years 4 Months | Current |
| Ashu Virmani | Director | 20 Jul 2022 | 4 Years 4 Months | Current |
| Ashish Virmani | Director | 26 May 1999 | 27 Years 5 Months | Current |
Peer comparison
Zaneka Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Morsef Pharmaceuticals Private Limited | ₹4.18 Cr (FY 2025) | -7.0% | Mumbai, Maharashtra, India | |||
| Fab Pharmaceuticals Private Limited | ₹4.18 Cr (FY 2025) | -29.0% | Bangalore, Karnataka, India | |||
| Zaneka Pharmaceuticals Private Limitedthis company | ₹4.17 Cr (FY 2025) | ₹6.37 Lakh | 1.5% | -3.0% | 17 | Haridwar, Uttarakhand, India |
| Adalbert Healthcare Private Limited | ₹4.16 Cr (FY 2023) | 6.0% | Mira Road, Maharashtra, India | |||
| Neutraciaa Lifesciences Private Limited | ₹4.16 Cr (FY 2024) | -11.0% | Siliguri, West Bengal, India |
To see the full peer comparison of Zaneka Pharmaceuticals Private Limited, buy the company report.
Auditor
Zaneka Pharmaceuticals Private Limited is audited by APV & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| APV & ASSOCIATES | FY 2023 | 123143W |
Shareholding
The shareholding of Zaneka Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Zaneka Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Feb 2021 | 100428225 | Axis Bank Limited | ₹50 Lakh | Open | |
| 27 Jan 2015 | 10570213 | Oriental Bank of Commerce | ₹40 Lakh | Open | |
| 23 Jan 2008 | 10090955 | State Bank of India | ₹20 Lakh | Satisfied | |
| 05 Feb 2003 | 90037845 | State Bank of India | ₹2 Lakh | Satisfied |
To see the full charge records of Zaneka Pharmaceuticals Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
Zaneka Pharmaceuticals Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
Cases on record (1 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Dehradun, Uttarakhand | Court case (Summary Trial) | Filed against the company by State Government | Disposed |
To see the full case history of Zaneka Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zaneka Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Zaneka Pharmaceuticals Private Limited has a workforce of 17 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 17 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Zaneka Pharmaceuticals Private Limited, buy the company report.
GST
Zaneka Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAACZ1224A1Z3 | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Zaneka Pharmaceuticals Private Limited, buy the company report.
Recent activity
Zaneka Pharmaceuticals Private Limited has 14 board changes on record since 1999: 8 appointments and 6 cessations. The latest: Ashu Virmani ceased to be Additional Director on 30 Sep 2022.
11 earlier events are in the company report.
Frequently asked questions
Zaneka Pharmaceuticals is an active private limited company based in Haridwar, Uttarakhand, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 May 1999 (27+ years old) and is registered under CIN U24231UR1999PTC001430.
Zaneka Pharmaceuticals has 8 current directors:
- Shifali - Director
- Satish Chand Virmani - Director
- Amit Virmani - Director
- Shantanu Virmani - Director
- Ashu Virmani - Director
- Ashish Virmani - Director
- Indu Batra - Director
- Lalit Mohan Batra - Director
The latest financial statements of Zaneka Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Zaneka Pharmaceuticals is 05AAACZ1224A1Z3, registered in Uttarakhand. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Zaneka Pharmaceuticals is U24231UR1999PTC001430. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zaneka Pharmaceuticals has 2 court cases on record: 2 filed against it.
Zaneka Pharmaceuticals was incorporated on 26 May 1999, making it 27+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Zaneka Pharmaceuticals by revenue are Morsef Pharmaceuticals Private Limited, Fab Pharmaceuticals Private Limited, Adalbert Healthcare Private Limited, Neutraciaa Lifesciences Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Ashu Virmani ceased to be Additional Director on 30 Sep 2022. Ashu Virmani was appointed as Director on 20 Jul 2022. Manju Virmani ceased to be Director on 20 Jul 2022. Zaneka Pharmaceuticals has 14 board changes on record in total.
Yes, Zaneka Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UK-06-0011501).
Zaneka Pharmaceuticals can be reached through the website zanekapharma.com. Its registered office is in Haridwar, Uttarakhand, India.

